Navigating new world of synthetic biology, East Bay startup lands $30M, maps future of drug discovery

Study will evaluate the safety, tolerability and pharmacokinetics (PK) of OCT-980 in healthy volunteers

Initiation of the study marks Octant’s transition to a clinical-stage company